Ranatuerin-2PLx, R2PLx

General Information


DCTPep ID  DCTPep03748

Peptide Name   Ranatuerin-2PLx, R2PLx

Sequence  GIMDTVKNAAKNLAGQLLDKLKCKITAC

Sequence Length  28

UniProt ID  A0A3P8MS06 

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Cancer therapy related peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C127H226N36O38S3

Absent amino acids  EFHPRSWY

Theoretical pI  9.24

Acidic residues  2

Basic residues  5

Polar residues  8

Molecular weight (Average)  2961.59

Molecular weight (Monoisotopic)  2959.6

Common amino acids  K

Net charge  3

Instability index (II)  3.78

Aliphatic index  108.21

Grand average of hydropathicity (GRAVY)  0.118

Half Life 
  30 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 125
  Abs 0.1% (=1 g/l) 0.042, assuming all pairs of Cys residues form cystines
  Ext. coefficient 0
  Abs 0.1% (=1 g/l) 0.000, assuming all Cys residues are reduced

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30279210

Title  A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12184

DCTPep is developed by Dr.Zheng's team.